Pharmacology/Therapy News http://www.mdlinx.com/HemeOncLinx/news.cfm/newspage/1/spec_id/17/subspec_id/398 Pharmacology/Therapy en-us Copyright 2009 MDLinx, Inc. <![CDATA[Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2987390 12/20/2009 Journal of Clinical Oncology]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2987390 <![CDATA[Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2987393 12/20/2009 Journal of Clinical Oncology]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2987393 <![CDATA[Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2987396 12/20/2009 Journal of Clinical Oncology]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2987396 <![CDATA[Strongly Enhanced Antitumor Activity of Trastuzumab and Pertuzumab Combination Treatment on HER2-Positive Human Xenograft Tumor Models]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2985685 12/20/2009 Cancer Research]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2985685